<DOC>
	<DOCNO>NCT02369042</DOCNO>
	<brief_summary>External measure thoracic fluid content ( TFC ) combine vital sign ( HR , respiratory rate ( RR ) , posture movement ) use technology develop Kyma Medical Technologies track clinical change acute in-hospital chronic outpatient heart failure patient .</brief_summary>
	<brief_title>KYMA Device : External Measure Thoracic Fluid Vital Signs</brief_title>
	<detailed_description>This prospective , single center , non-randomized study design correlate Kyma measurement in-hospital parameter well change TFC vital sign clinical change outpatient set 60 day post-discharge . The patient hospital study personnel blind Kyma data capture device . No intervention perform patient base Kyma device data , observational study . The goal study : 1 . Follow thoracic fluid vital sign acute , hospitalize heart failure ( HF ) patient evidence volume overload evaluate combine parameter relation decongestion ( time clear lung auscultation clear congestion chest x-ray decrease BNP 50 % ) , clinical symptom , physical exam , biomarker result . 2 . Evaluate relationship lung decongestion externally measure hemodynamic parameter measure pulmonary artery catheter subset patient 3 . Correlate change thoracic fluid content vital sign clinical change outpatient set 60 day post-discharge . 4 . Evaluate feasibility implement physician-directed , patient- manage model diuretic vasodilator adjustment . Patients approach enrollment within 24 hour presentation hospital . The Kyma device apply patient . Data automatically collect device : TFC measure every 30 minute vital sign measure several time hour . Information collect baseline study coordinator include medication , lab work ( CBC , Chemistry , BNP ) , ejection fraction ( EF ) , weight , vital sign , lung auscultation Cohorts . Cohorts I II may enrol concurrently . For patient enrolled Cohort I , PA read record baseline 3 time daily pulmonary artery ( PA ) catheter remove . While hospitalize , patient daily weight , intake/output , Physical Exams ( edema , jugular venous distention ( JVP ) , lung exam ) vital sign record twice daily . Lab result record well change medication . After hospital discharge , patient wear Kyma device additional 60 day . Patients contact telephone 10 day , 30 day , 60 day post-discharge weight measurement , medication change , assessment Office Visits , ER/Hospitalizations SOB . The Minnesota Living Heart Failure Questionnaire administer hospital discharge 30 60 day post-discharge .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Cohort I 1 . Men woman 18 year age 2 . Admitted primary diagnosis HF 3 . Already assigned indwell PA catheter monitor 4 . BNP &gt; 400 5 . Two follow : edema , JVP &gt; 7cm , rales 6 . Currently assess clinically indicated hemodynamic monitoring Cohort II 1 . Men woman 18 year age 2 . Admitted primary diagnosis HF 3 . BNP &gt; 400 4 . Two follow : edema , JVP &gt; 7cm , rales 5 . Patients without hemodynamic monitoring use Cohort I II 1 . Patients allergy skin sensitivity electrode hydrogel and/or acrylic base adhesive 2 . Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>